Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TENOFOVIR | 300MG | TABLET | Resolved | 2020-09-30 | 2020-11-16 | 125338 |
| APO-TERAZOSIN | 10MG | TABLET | Resolved | 2018-10-02 | 2018-12-27 | 62871 |
| APO-TERAZOSIN | 2MG | TABLET | Resolved | 2018-10-19 | 2018-12-27 | 65008 |
| APO-TERAZOSIN | 1MG | TABLET | Resolved | 2017-06-28 | 2017-10-17 | 14250 |
| APO-TERAZOSIN | 1MG | TABLET | Resolved | 2023-06-16 | 2024-04-02 | 195250 |
| APO-TERAZOSIN | 2MG | TABLET | Resolved | 2023-06-16 | 2024-04-02 | 195253 |
| APO-TERAZOSIN | 5MG | TABLET | Resolved | 2023-06-16 | 2024-04-02 | 195256 |
| APO-TERAZOSIN | 10MG | TABLET | Resolved | 2023-06-16 | 2024-05-10 | 195259 |
| APO-TERAZOSIN | 5MG | TABLET | Resolved | 2024-04-12 | 2024-05-10 | 224999 |
| APO-TERAZOSIN | 2MG | TABLET | Resolved | 2024-04-26 | 2024-05-10 | 226330 |
| APO-TERAZOSIN | 5MG | TABLET | Resolved | 2017-09-27 | 2017-10-24 | 23655 |
| APO-TERAZOSIN | 10MG | TABLET | Resolved | 2018-01-17 | 2018-07-31 | 36350 |
| APO-TERAZOSIN | 5MG | TABLET | Resolved | 2018-01-17 | 2018-07-31 | 36353 |
| APO-TERAZOSIN | 1MG | TABLET | Resolved | 2018-01-31 | 2018-07-31 | 37743 |
| APO-TERAZOSIN | 2MG | TABLET | Resolved | 2018-02-01 | 2018-08-20 | 37986 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2017-11-01 | 2017-11-23 | 27773 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-01-31 | 2018-09-21 | 37746 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37989 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2017-05-24 | 2017-07-19 | 11053 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2017-08-08 | 2017-09-22 | 18567 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |